Search for: "Ely Lilly" Results 601 - 620 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 May 2014, 9:45 pm by Patent Docs
The conference will provide optimal strategies to help attendees maximize their patent portfolios, including: • The radical SPC decisions in Georgetown University, Actavis and Eli Lilly; • Capitalise on second medical use patents by implementing proven strategies and utilising tactical enforcement and remedial methods; • Fundamental update on the imminent Unitary Patent and Unified Patent Court and how to adapt business strategies effectively; • The… [read post]
12 Dec 2015, 9:17 pm by Patent Docs
Carla Mouta of Finnegan Henderson Farabow Garrett & Dunner, LLP will moderate a panel consisting of Kenneth Jenkins of Mintz Levin, PC; Suzannah Sundby of Canady + Lortz, LLP; and Robert Titus of Eli Lilly and Company. [read post]
7 Jun 2019, 11:33 am by IPWatchdog
This week in Other Barks & Bites: the Wisconsin Alumni Research Foundation's petition to the Supreme Court in a case against Apple; AAG Makan Delrahim's remarks about misuse of antitrust law by U.S. courts; Eli Lilly's petition to the Supreme Court regarding functional claiming rule; cert granted in Allen v. [read post]
12 Aug 2014, 9:55 pm by Patent Docs
Both these assumptions are thrown into doubt by the Patent Court's decision in Actavis v Eli Lilly[2]. [read post]
22 Feb 2011, 6:39 pm by Greg Siskind
In a similar vein, Indiana Governor Mitch Daniels got a warning from his former employer Eli Lilly that his signing an Arizona-style bill could seriously damage Indiana employers' ability to recruit top talent. [read post]
29 Oct 2020, 10:00 pm by Laurent Teyssèdre
 Avocat et Docteur en droit, Matthieu est aussi Chercheur à l’Institut Max-Planck pour l’Innovation et la Concurrence ainsi que Président de l'Institut Stanislas de Boufflers.Rejoignant la majorité des tribunaux européens, le Tribunal Judiciaire de Paris a jugé que le brevet d’Eli Lilly, qui porte sur l’administration combinée de [read post]
29 Aug 2015, 8:15 pm by Patent Docs
Vorndran-Jones of Eli Lilly and Company will provide guidance to IP counsel for calculating patent term adjustments, interplay with patent term extensions, examine recent court treatment, and offer approaches for preserving rights and maximizing patent term adjustments and patent term extensions. [read post]
28 Nov 2022, 9:07 pm by Patent Docs
Food and Drug Administration (FDA) announced its approval of Eli Lilly's Rezvoglar (insulin glargine-aglr) product as an interchangeable biosimilar to Sanofi's Lantus (insulin glargine). [read post]
18 Mar 2020, 9:55 pm by Patent Docs
In three cases (stemming in one instance from a Federal Circuit opinion consolidated from two cases in the district court, by Eli Lilly & Co. against two ANDA defendants),... [read post]
5 Aug 2012, 7:28 pm by Patent Docs
Armitage, Senior Vice President and General Counsel for Eli Lilly and Company, and Thomas W. [read post]
7 Jun 2019, 11:33 am by IPWatchdog
This week in Other Barks & Bites: the Wisconsin Alumni Research Foundation's petition to the Supreme Court in a case against Apple; AAG Makan Delrahim's remarks about misuse of antitrust law by U.S. courts; Eli Lilly's petition to the Supreme Court regarding functional claiming rule; cert granted in Allen v. [read post]
1 Aug 2014, 8:58 pm by Patent Docs
Ned Israelsen of Knobbe, Martens, Olson & Bear, LLP; Jonathan Singer of Fish & Richardson, PC; and Mark Stewart of Eli Lilly and Co. will examine the impact of the U.S. [read post]
4 Mar 2023, 8:45 pm by Patent Docs
Irving of Finnegan Henderson Farabow Garrett & Dunner, Sarah Hooson of Merck Sharp & Dohme, Krista Kostiew of Unilever, and Xiaoguang Michelle Gao of Eli Lilly and Company will guide patent counsel on recent trends and developments in patent practice; examine the Supreme Court, Federal Circuit, and PTAB cases from the past year; and discuss some of the key developments and strategies.... [read post]
23 Sep 2013, 9:59 pm by Patent Docs
By Donald Zuhn -- Last week, a coalition of more than 100 companies and organizations including the Biotechnology Industry Organization (BIO), the California Healthcare Institute (CHI), and Eli Lilly & Company, sent a letter to Congressional leaders to express their "opposition to recent legislative proposals expanding the America Invents Act's 'covered business method patent' program." [read post]
2 May 2016, 9:59 pm by Patent Docs
Links to each of the filed briefs can be found below: • Brief for Amici Curiae Eli Lilly and Company, Eisai Inc., Upsher-Smith Laboratories, Inc., Pfizer Inc., and Etiometry, Inc. in Support of Petitioner (brief) • Brief of Amicus Curiae by The Chartered Institute... [read post]
20 Jan 2007, 1:25 am
We haven't yet heard the results of the two-day hearing before Judge Weinstein over the propriety of his injunction seeking to recover internal Eli Lilly documents about Zyprexa that were leaked to the New York Times and elsewhere. [read post]
16 Jan 2021, 9:58 pm by Patent Docs
Tom Irving of Finnegan of Henderson, Farabow, Garrett & Dunner, LLP will moderate a panel consisting of Daniela Gill-Carey of UCB Biopharma, Sarah Hooson of Merck, and Margaret Tomaska of Eli Lilly and Co. [read post]